SVRA
Savara Inc
NASDAQ · Healthcare · Biotechnology · US
$4.63
+4.04%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-97.0%
Return on equity
-72.5%
Return on assets
-82.7%
Return on invested capital
0.00x
Asset turnover
-$110.4M
Cash from operations
$0.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026